In this article, we take a look at five stocks that are skyrocketing today. If you want to take a look at some more stocks that are rising today and the latest market situation, go to These 10 Stocks Are Skyrocketing Today.
5. Calix, Inc. (NYSE:CALX) has risen 5.1% as of 11:19 AM ET after the San Jose, California-based cloud and software provider has been tapped by Brightspeed. Brightspeed intends to start the design and deployment of its fiber optics network buildout and intends to cover 20 states through its operations. It will begin the rollout from North Carolina in Q3 2022. Brightspeed will bring into play the cloud platforms of Calix, Inc. (NYSE:CALX) in providing its services from the access edge to the customer premises.
As of Q4 2021, 21 hedge funds had a holding in Calix, Inc. (NYSE:CALX), with a cumulative stake of $723.3 million.
4. Vector Group Ltd. (NYSE:VGR) has climbed 16.4% as of 11:35 AM ET after the Miami, Florida-based tobacco and real estate diversified holding company was upgraded by Pallav Mittal at Barclays from an Equal Weight to an Overweight rating. The price target also received an upward revision of 33% from $12 to $16. The analyst anticipates Vector Group Ltd. (NYSE:VGR) to enjoy volumetric gains for its deep discount brand Montego this year as the customers would be forced to switch towards economical offerings in times of high inflation.
Of the 924 hedge funds in Insider Monkey’s database, 23 funds held a stake in Vector Group Ltd. (NYSE:VGR) as of Q4 2021.
3. Clovis Oncology (NASDAQ:CLVS) has risen over 30% as of 1 PM ET. The biotech company revealed that it had met the key goal for an ovarian cancer treatment called Rubraca (Rucaparib). The data point is based on a Phase 3 trial conducted by Clovis Oncology (NASDAQ:CLVS) on 538 patients. The data revealed that on median data, patients receiving Rubraca lived 20.2 months without any progression in the disease as opposed to 9.2 months for the placebo.
As of Q4 2021, Clovis Oncology (NASDAQ:CLVS) was held by 16 hedge funds, up from 11 in the previous quarter.
2. Nano-X Imaging Ltd. (NASDAQ:NNOX) is up 16.5% as of 12:03 PM ET after the producer and seller of digital X-Ray source technology reported better than expected Q4 2021 results today. Revenue for the three months was posted at $1.3 million, compared to the analysts’ forecast of $750,000. Furthermore, Nano-X Imaging Ltd. (NASDAQ:NNOX) reported a loss per share of 30 cents, three cents lower than the analysts’ forecast.
Overall, 11 hedge funds had a position in Nano-X Imaging Ltd. (NASDAQ:NNOX) as of Q4 2021, up from 9 in the preceding quarter.
1. Longeveron Inc. (NASDAQ:LGVN) is up 72.4% as of 12:15 PM ET after the company disclosed peer-reviewed results of the Phase 1 trial for its Alzheimer’s disease candidate Lomecel-B. It is a cell-based therapy offering obtained from the bone marrow of young and healthy donors. The Phase 1 trial was conducted on 33 patients, who were suffering from mild Alzheimer’s. The trial met the primary endpoint and reflected that it was well-tolerated amongst patients. Greg Eisner-led Engineers Gate Manager is the only hedge fund with a stake in Longeveron Inc. (NASDAQ:LGVN) as of Q4 2021.
You can also take a peek at the 10 Commodity Dividend Stocks With Over 4% Yield and 10 Fertilizer Stocks to Buy Today.
